ausbiz interview 21 October 2020 – Uranium
Michael Goldberg, Managing Director and Portfolio Manager at Collins St Asset Management, is interviewed on the ausbiz program about his outlook for ASX listed uranium stocks.
Michael Goldberg on ausbiz 10 August 2020
Michael Goldberg, Managing Director and Portfolio Manager at Collins St Asset Management is interviewed on the ausbiz business show about his views on the Buy Now Pay Later sector and also the dislocation between markets and the economy. Filmed on the 10th of August 2020.
Michael Goldberg ausbiz interview 29 July 2020
Michael Goldberg, Managing Director and Portfolio Manager at Collins St Asset Management, is interviewed on the ausbiz business program about his views on the Federal Government’s mini budget and the outlook for the ASX reporting season.
The markets are expensive and it doesn’t matter!
The 2020 Financial Year certainly threw up some challenges. To think the biggest global issues investors were contemplating only 12 months ago included the UK’s dealing of Brexit and the transition of the Prime Ministership from Theresa May to Boris Johnson! Six months ago, the world was enthralled and slightly wary as the USA and […]
ausbiz 29 June 2020
Rob Hay, Head of Distribution & Investor Relations at Collins St Asset Management appears on the ausbiz business program. Key stocks discussed include Victory Offices (VOL.ASX).
ausbiz 15 June 2020
Rob Hay, Head of Distribution & Investor Relations at Collins St Asset Management appears on the ausbiz business program to discuss ASX listed gold stocks.
ausbiz 1 June 2020
Rob Hay, Head of Distribution & Investor Relations at Collins St Asset Management appears on the ausbiz business program to discuss ASX listed energy and resource stocks.
EPS of $20 by 2025? Progress and Profile to Power Paradigm’s Share Price
Paradigm Biopharmaceuticals (PAR.ASX) have $108M in cash, no debt and are well advanced in the progression of clinical trials in addressable markets worth up to as much as $36B p.a. The next two years are particularly exciting for Paradigm Biopharmaceuticals as they are set to announce: Complete recruitment of 1150 patients for the stage 3-clinical […]
ausbiz 18 May 2020
Michael Goldberg, Managing Director & Portfolio Manager at Collins St Asset Management appears on the auzbis business program. Key stocks discussed include iSelect (ISU.ASX) and National Tyre & Wheel (NTD.ASX).